Meds A-Z
Thiabendazole
Detailed information about Thiabendazole
Pet Owner Quick Guide
Start here: what this medicine is for, what it does, and when it's usually needed.
Usually used for:
For control of infections of gastrointestinal roundworms ( Trichostrongylus , Haemonchus Ostertagia , and Cooperia ).
What it does:
For control of infections of gastrointestinal roundworms in sheep and goats. (Trichostrongylus species, Haemonchus species, Ostertagia species, Cooperia species, Nematodirus species, Bunostomom species, Strongyloides spe...
When it's needed:
As a single oral dose. Milk taken from animals during treatment and within 96 hours (8 milkings) after the latest treatment must not be used for food. In severe infections in sheep, treatment should be repeated in 2 to 3...
Call your vet sooner if you notice:
- As a single oral dose. Milk taken from animals during treatment and within 96 hours (8 milkings) after the latest treatment must not be used for food. In severe infections in sheep, treatment should be repeated in 2 to 3 weeks. As a single oral dose. Milk taken from animals during treatment and within 96 hours (8 milkings) after the latest treatment must not be used for food. As a single oral dose. Milk taken from treated animals within 96 hours (8 milkings) after the latest treatment must not be used for food. Treatment should be repeated in 2 to 3 weeks.
Commonly reported reactions:
- (1 reports)
- (1 reports)
- (1 reports)
What to ask your vet today:
- Is this medicine the right fit for my pet’s current symptoms?
- Which warning signs mean I should call back right away?
- How should I handle missed doses or refusal to take the medicine?
Thiabendazole
Drug type: Generic ingredient • Branded profile • FDA branded products available
Species: Both
Manufacturer: Boehringer lngelheim Animal Health USA Inc.
Quick Facts
Official label facts first, then secondary summaries. Marketing content is separated below.
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/42910 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/30578 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Medication usage source
Warnings / Contraindications
As a single oral dose. Milk taken from animals during treatment and within 96 hours (8 milkings) after the latest treatment must not be used for food. In severe infections in sheep, treatment should be repeated in 2 to 3 weeks. As a single oral dose. Milk taken from animals during treatment and within 96 hours (8 milkings) after the latest treatment must not be used for food. As a single oral dose. Milk taken from treated animals within 96 hours (8 milkings) after the latest treatment must not be used for food. Treatment should be repeated in 2 to 3 weeks.
- High: As a single oral dose. Milk taken from animals during treatment and within 96 hours (8 milkings) after the latest treatment must not be used for food. In severe infections in sheep, treatment should be repeated in 2 to 3 weeks. As a single oral dose. Milk taken from animals during treatment and within 96 hours (8 milkings) after the latest treatment must not be used for food. As a single oral dose. Milk taken from treated animals within 96 hours (8 milkings) after the latest treatment must not be used for food. Treatment should be repeated in 2 to 3 weeks.
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Contraindication source
Adverse Reactions
Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.
Tap or hover a reaction to see what it means in plain language.
Most Reported Reactions
| Reaction | Cases | Species | Serious cases |
|---|---|---|---|
| 1 | Cat | 1 | |
| 1 | Dog | 1 | |
| 1 | Cat | 0 | |
| 1 | Dog | 0 | |
| 1 | Cat | 0 | |
| 1 | Dog | 0 | |
| 1 | Cat | 0 | |
| 1 | Dog | 0 |
Species coverage: Cat (20) Dog (12)
View detailed reaction table
| Reaction | Species | Seriousness | Frequency | Reports |
|---|---|---|---|---|
| Cat | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - |
- https://api.fda.gov/animalandveterinary/event.json · adverse_reaction · openFDA case USA-USFDACVM-2025-US-056132
Storage & Handling
No storage/handling guidance is linked yet.
Documents
Official label facts are separated from secondary summaries.
Official documents: 26 • Secondary summaries: 0
- E-Z-EX Wormer Mintrate Block · SPL
- E-Z-EX Wormer Pellets · SPL
- Equizole® · SPL
- Equizole® 50% Wormer Paste For Horses · SPL
- Equizole® 50% Wormer Paste · SPL
- Equizole® A · SPL
- Equizole® A Liquid · SPL
- Equizole® Horse Wormer · SPL
- Equizole® Horse Wormer Pellets · SPL
- Omnizole · SPL
- UCM452230.pdf · FOI
- TBZ 200 Medicated Feed Premix · SPL
- TBZ® Cattle Wormer (Drench) · SPL
- TBZ® Wormer Paste 43% · SPL
- TBZ® Wormer Paste 50% · SPL
- Thibenzole (18 mg) · SPL
- Thibenzole 20% Swine Premix · SPL
- Thibenzole 300 Medicated · SPL
- Thibenzole Pig Wormer · SPL
- Thibenzole Sheep & Goat Wormer · SPL
- Purina® Horse Wormer Medicated · SPL
- Equizole®-B · SPL
- Equivet-14 · SPL
- UCM457231.pdf · FOI
- Thiabendazole, Dexamethasone, Neomycin Sulfate Solution · SPL
- Tresaderm Dermatologic Solution · SPL
No source yet.
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/787/E-Z-EX%20Wormer%20Mintrate%20Block · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1153/E-Z-EX%20Wormer%20Pellets · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/377/Equizole%C2%AE · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2526/Equizole%C2%AE%2050%25%20Wormer%20Paste%20For%20Horses · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2525/Equizole%C2%AE%2050%25%20Wormer%20Paste · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/431/Equizole%C2%AE%20A · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/891/Equizole%C2%AE%20A%20Liquid · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1671/Equizole%C2%AE%20Horse%20Wormer · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/811/Equizole%C2%AE%20Horse%20Wormer%20Pellets · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1692/Omnizole · document · SPL
Promotional Materials (Marketing)
This content is marketing material and not clinical guidance.
No marketing assets are linked yet.
No source yet.
Technical appendix (vet reference)
Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.
At a Glance
Quick facts and links to official labeling and safety signals.
- Medication catalog: Source PetWisePlus | Refreshed Feb 12, 2026, 10:44 PM UTC
-
Animal Drugs @ FDA:
Source FDA
| Refreshed Feb 16, 2026, 11:00 AM UTC
Applications/products are imported from FDA export data.
-
Animal Drugs @ FDA previews:
Source FDA
| Refreshed Feb 9, 2026, 3:05 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
-
Animal Drug Product Listing Directory (NDC):
Source FDA
| Refreshed Feb 16, 2026, 11:00 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
- openFDA reaction terms: Source FDA openFDA | Refreshed Feb 16, 2026, 11:05 AM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Feb 9, 2026, 3:22 AM UTC
Counseling and Monitoring Highlights
Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.
- As a single oral dose. Milk taken from animals during treatment and within 96 hours (8 milkings) after the latest treatment must not be used for food. In severe infections in sheep, treatment should be repeated in 2 to 3 weeks. As a single oral dose. Milk taken from animals during treatment and within 96 hours (8 milkings) after the latest treatment must not be used for food. As a single oral dose. Milk taken from treated animals within 96 hours (8 milkings) after the latest treatment must not be used for food. Treatment should be repeated in 2 to 3 weeks. (Contraindication, High)
Identifiers & Packages
Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.
| Package NDC | Product NDC | Form / Route | Status |
|---|---|---|---|
| 0010-5587-01 | 0010 | - | |
| 0010-5587-02 | 0010 | - | |
| 0010-5587-03 | 0010 | - | |
| 0010-5587-04 | 0010 | - | |
| 66651-101-11 | 66651 | - | |
| 66651-101-12 | 66651 | - | |
| 66651-101-13 | 66651 | - | |
| 66651-101-14 | 66651 | - | |
| 66651-101-15 | 66651 | - | |
| 66651-101-16 | 66651 | - | |
| 66651-101-17 | 66651 | - |
Enriched Documents
Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.
-
UCM452230.pdf
• FOI summary • Official
• May 3, 2023
FDA FOI summary for application 15875
-
UCM457231.pdf
• FOI summary • Official
• June 1, 2016
FDA FOI summary for application 200565
Data Sources & Revision History
Every non-trivial field is expected to include provenance and update timestamps.
- contraindications: As a single oral dose. Milk taken from animals during treatment and within 96 hours (8 milkings) after the latest treatment must not be used for food. In sever… (Official, 2026-02-12)
- side_effects: Top reported reactions (openFDA): Lethargy (see also Central nervous system depression in 'Neurological'), Loss of hearing, Deafness, Lack of efficacy - NOS, V… (Official, 2026-02-12)
- usage: For control of infections of gastrointestinal roundworms in sheep and goats. (Trichostrongylus species, Haemonchus species, Ostertagia species, Cooperia specie… (Official, 2026-02-12)
- side_effects updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
FDA Products & Applications (Animal Drugs @ FDA)
Official sponsor/proprietary-name/application-status records linked by active ingredient.
| Product | Sponsor | Application | Status | Published |
|---|---|---|---|---|
|
E-Z-EX Wormer Mintrate Block
OTC
Thiabendazole
Medicated Feed Block
• Oral
|
ADM Animal Nutrition | NADA 42910 | W | Feb 27, 2024 |
|
E-Z-EX Wormer Pellets
OTC
Thiabendazole
Pellet
• Oral
|
ADM Animal Nutrition | NADA 30578 | W | Feb 27, 2024 |
|
Equizole®
OTC
Thiabendazole
Suspension
• Oral
|
Boehringer lngelheim Animal Health USA Inc. | NADA 34114 | W | May 3, 2023 |
|
Equizole® 50% Wormer Paste For Horses Equizole® 50% Wormer Paste
OTC
Thiabendazole
Paste
• Oral
|
Boehringer lngelheim Animal Health USA Inc. | NADA 98689 | W | May 3, 2023 |
|
Equizole® A
RX
Piperazine Phosphate Thiabendazole
Paste
• Oral
|
Boehringer lngelheim Animal Health USA Inc. | NADA 37410 | W | May 3, 2023 |
|
Equizole® A Liquid
RX
Piperazine Citrate Thiabendazole
Liquid
• Nasogastric, Oral
|
Boehringer lngelheim Animal Health USA Inc. | NADA 47333 | W | May 3, 2023 |
|
Equizole® Horse Wormer
RX
Thiabendazole
Top Dressing In Feed
• Oral
|
Boehringer lngelheim Animal Health USA Inc. | NADA 13407 | W | May 3, 2023 |
|
Equizole® Horse Wormer Pellets
OTC
Thiabendazole
Top Dressing In Feed
• Oral
|
Boehringer lngelheim Animal Health USA Inc. | NADA 44654 | W | May 3, 2023 |
|
Omnizole
OTC
Thiabendazole
Drench
• Oral
|
Boehringer lngelheim Animal Health USA Inc. | NADA 14350 | W | May 3, 2023 |
|
TBZ 200 Medicated Feed Premix
OTC
Thiabendazole
Medicated Feed
• Oral
|
Boehringer lngelheim Animal Health USA Inc. | NADA 15875 | W | May 3, 2023 |
|
TBZ® Cattle Wormer (Drench)
OTC
Thiabendazole
Liquid (Solution)
• Oral
|
Boehringer lngelheim Animal Health USA Inc. | NADA 15123 | W | May 3, 2023 |
|
TBZ® Wormer Paste 43%
OTC
Thiabendazole
Paste
• Oral
|
Boehringer lngelheim Animal Health USA Inc. | NADA 49461 | W | May 3, 2023 |
|
TBZ® Wormer Paste 50%
OTC
Thiabendazole
Paste
• Oral
|
Boehringer lngelheim Animal Health USA Inc. | NADA 48487 | W | May 3, 2023 |
|
Thibenzole (18 mg)
OTC
Thiabendazole
Drench
• Oral
|
Boehringer lngelheim Animal Health USA Inc. | NADA 30103 | W | May 3, 2023 |
|
Thibenzole 20% Swine Premix
OTC
Thiabendazole
Medicated Feed
• Oral
|
Boehringer lngelheim Animal Health USA Inc. | NADA 13954 | W | May 3, 2023 |
|
Thibenzole 300 Medicated
OTC
Thiabendazole
Paste
• Oral
|
Boehringer lngelheim Animal Health USA Inc. | NADA 43141 | W | May 3, 2023 |
|
Thibenzole Pig Wormer
OTC
Thiabendazole
Paste
• Oral
|
Boehringer lngelheim Animal Health USA Inc. | NADA 35631 | W | May 3, 2023 |
|
Thibenzole Sheep & Goat Wormer
OTC
Thiabendazole
Liquid (Solution)
• Oral
|
Boehringer lngelheim Animal Health USA Inc. | NADA 13022 | W | May 3, 2023 |
|
Purina® Horse Wormer Medicated
OTC
Thiabendazole
Top Dressing In Feed
• Oral
|
Virbac AH, Inc. | NADA 40205 | W | Mar 15, 2019 |
|
Equizole®-B Equivet-14
RX
Thiabendazole Trichlorfon
Liquid
• Oral, Nasogastric
|
Farnam Companies, Inc. | NADA 91067 | Approved | Jun 1, 2016 |
|
Thiabendazole, Dexamethasone, Neomycin Sulfate Solution
RX
Dexamethasone Neomycin Sulfate Thiabendazole
Solution
• Topical
|
Dechra Veterinary Products LLC | ANADA 200-565 | Approved | Jun 1, 2016 |
|
Tresaderm Dermatologic Solution
RX
Dexamethasone Neomycin Sulfate Thiabendazole
Liquid (Solution)
• Topical
|
Boehringer lngelheim Animal Health USA, Inc. | NADA 42633 | Approved | Jun 1, 2016 |
Data source: FDA Animal Drugs @ FDA (public search export).
What It's For (FDA Label Highlights)
Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
It is administered to horses by stomach tube or as a drench at the rate of 1 fluid ounce of suspension per 100 pounds of body weight.
Do not use in horses intended to be used for food purposes. For use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Control of infections of gastrointestinal roundworms (Trichostrongylus species, Haemonchus species, Ostertagia species, Cooperia species; Nematodirus species, ,i>Bunostomum species, Strongyloides species, Chabertia species, and Oesophagostomum species); also active against ova and larvae passed by sheep from 3 hours to 3 days after the feed is consumed (good activity against ova and larvae of T. colubriformis and T.axei, Ostertagia species, Nematodirus species, Strongyloides species; less effective against those of Haemonchus contortus and Oesophagostomum species).
Control of severe infections of gastrointestinal roundworms (Trichostrongylus species, Haemonchus species, Ostertagia species, Nematodirus species, Oesophagostomum radiatum); control of infections of Cooperia species.
Control of infections of gastrointestinal roundworms (Trichostrongylus species, Haemonchus species, Ostertagia species, Nematodirus species, Oesophagostomum radiatum).
Control of infections of gastrointestinal roundworms (Trichostrongylus species, Haemonchus species, Ostertagia species, Cooperia species; Nematodirus species, Bunostomum species, Strongyloides species, Chabertia species, and Oesophagostomum species); also active against ova and larvae passed by sheep from 3 hours to 3 days after the feed is consumed (good activity against ova and larvae of T. colubriformis and T. axei, Ostertagia species, Nematodirus species, Strongyloides species; less effective against those of Haemonchus contortus and Oesophagostomum species).
Control of severe infections of gastrointestinal roundworms (Trichostrongylus species, Haemonchus species, Ostertagia species, Cooperia species, Nematodirus species, Bunostomum species, Strongyloides species, Chabertia species, and Oesophagostomum species).
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For control of large and small strongyles, Strongyloides, and pinworms of the genera Strongylus, Cyathostomum, Cylicobrachytus and related genera, Craterostomum, Oesophagodontus, Poteriostomum, Oxyuris, and Strongyloides.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Official Documents (FDA)
Direct links to FDA-hosted PDFs and SPL packages (when available).
FDA page: Open in Animal Drugs @ FDA
- E-Z-EX Wormer Pellets (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Equizole® (ZIP)
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
- Equizole® A (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Equizole® A Liquid (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Equizole® Horse Wormer (ZIP)
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
- Omnizole (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM452230.pdf
Summary
This supplement provides for the addition of the indication for treatment of gapeworms ( Syngamus trachea) in pheasants.
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
- TBZ® Wormer Paste 43% (ZIP)
FDA page: Open in Animal Drugs @ FDA
- TBZ® Wormer Paste 50% (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Thibenzole (18 mg) (ZIP)
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
- Thibenzole 300 Medicated (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Thibenzole Pig Wormer (ZIP)
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
- Equizole®-B (ZIP)
- Equivet-14 (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM457231.pdf
Summary
As an aid in the treatment of certain bacterial, mycotic, and inflammatory dermatoses and otitis externa in dogs and cats.
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
Usage
For control of infections of gastrointestinal roundworms in sheep and goats. (Trichostrongylus species, Haemonchus species, Ostertagia species, Cooperia species, Nematodirus species, Bunostomom species, Strongyloides species, Chabertia species, and Oesophagostomum species); also active from 3 hours to 3 days following treatment against ova and larvae passed by sheep (good activity against Trichostrongylus colubriformis and axei, Ostertagia species, Bunostomom species, Nematodirus species, Strongyloides species; less effective against Haemonchus contortus and Oesophagostomum species). Control of severe infections of gastrointestinal roundworms (Trichostrongylus species, Haemonchus species, Ostertagia species, Cooperia species, Nematodirus species, Bunostomom species, Strongyloides species, Chabertia species, and Oesophagostomum species). For control of large and small strongyles, Strongyloides, and pinworms of the genera Strongylus, Cyathostomum, Cylicobrachytus and related genera, Craterostomum, Oesophagodontus, Poteriostomum, Oxyuris, and Strongyloides.
Source: FDA Animal Drugs @ FDA • Reference
Contraindications
As a single oral dose. Milk taken from animals during treatment and within 96 hours (8 milkings) after the latest treatment must not be used for food. In severe infections in sheep, treatment should be repeated in 2 to 3 weeks. As a single oral dose. Milk taken from animals during treatment and within 96 hours (8 milkings) after the latest treatment must not be used for food. As a single oral dose. Milk taken from treated animals within 96 hours (8 milkings) after the latest treatment must not be used for food. Treatment should be repeated in 2 to 3 weeks.
Side Effects
No approved side-effect narrative is linked yet.
openFDA reaction signals are available for Dog 8 and Cat 56 (view top reported reactions).
Top Reported Reactions (openFDA)
Aggregated reaction terms from FDA openFDA reports (not verified; does not prove causation).
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Adverse Event Case Summaries (openFDA)
These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.
Cat, Domestic Shorthair, Male, 3 year, 5.65 kilogram • Drug: MSK, Topical, Dose: 6 drops per animal, Frequency: 12 per hour • Reactions: Tiredness (lethargy), Vomiting, Otitis media, Tympanic alteration, Abnormal radiograph finding… • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-056132
- Serious AE: No
- Treated For AE: Yes
- Sex: Male
- Age: 3.00 Year
- Weight: 5.650 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Topical
- Dose: 6 drops per animal
- Frequency: 12 per hour
Cat, Cat (unknown), Unknown • Drug: MSK, Unknown • Reactions: Increased drinking, Reluctant to move, Tiredness (lethargy) • Outcome: Recovered/Normal
- Report ID: USA-USFDACVM-2025-US-054681
- Serious AE: No
- Treated For AE: No
- Sex: Unknown
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Cat, American Shorthair, Female, 6 year, 4.781 kilogram • Drug: MSK, Auricular (Otic), Dose: 6 drops per animal, Frequency: 12 per hour • Reactions: Unsteady walking (ataxia), Loss of appetite, Nystagmus • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-054206
- Serious AE: No
- Treated For AE: Yes
- Sex: Female
- Age: 6.00 Year
- Weight: 4.781 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Auricular (Otic)
- Dose: 6 drops per animal
- Frequency: 12 per hour
Cat, Domestic Shorthair, Male, 8 year, 6.713 kilogram • Drug: MSK, Auricular (Otic) • Reactions: Tiredness (lethargy), Decreased appetite • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-055591
- Serious AE: No
- Treated For AE: No
- Sex: Male
- Age: 8.00 Year
- Weight: 6.713 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Auricular (Otic)
Cat, British cat, Female, 18 month, 3.311 kilogram • Drug: MSK, Auricular (Otic), Dose: 5 drops per animal • Reactions: Loss of hearing • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-052431
- Serious AE: Yes
- Treated For AE: No
- Sex: Female
- Age: 18.00 Month
- Weight: 3.311 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Auricular (Otic)
- Dose: 5 drops per animal
Dog, Rottweiler, Female, 3 year, 42.41 kilogram • Drug: MSK • Reactions: Ear discharge • Outcome: Recovered/Normal
- Report ID: USA-USFDACVM-2025-US-046347
- Serious AE: No
- Treated For AE: No
- Sex: Female
- Age: 3.00 Year
- Weight: 42.410 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
Dog, Chihuahua, Male, 3 month, 2.041 kilogram • Drug: MSK, Topical, Dose: 4 drops per animal, Frequency: 12 per hour • Reactions: Scratching, Vocalisation, Pinnal ulcer • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-037451
- Serious AE: No
- Treated For AE: Yes
- Sex: Male
- Age: 3.00 Month
- Weight: 2.041 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Topical
- Dose: 4 drops per animal
- Frequency: 12 per hour
Dog, Retriever - Golden, Male, 8 week, 7.257 kilogram • Drug: MSK, Unknown • Reactions: Leucocytosis NOS, Anaemia NOS, Decreased blood urea nitrogen (BUN) or creatinine, Other abnormal test result NOS, Ear discharge… • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-036873
- Serious AE: No
- Treated For AE: Yes
- Sex: Male
- Age: 8.00 Week
- Weight: 7.257 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Overdose Information
No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.
Storage & Handling
No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.
Share Your Thoughts
Let others know your experience or advice regarding this medication.
This medication has not been reviewed by a veterinarian yet.